Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rxo (RXO) Other Working Capital Changes (2021 - 2025)

Historic Other Working Capital Changes for Rxo (RXO) over the last 5 years, with Q4 2025 value amounting to $1.0 million.

  • Rxo's Other Working Capital Changes fell 9285.71% to $1.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$19.0 million, marking a year-over-year decrease of 13750.0%. This contributed to the annual value of -$19.0 million for FY2025, which is 13750.0% down from last year.
  • As of Q4 2025, Rxo's Other Working Capital Changes stood at $1.0 million, which was down 9285.71% from -$27.0 million recorded in Q3 2025.
  • Over the past 5 years, Rxo's Other Working Capital Changes peaked at $14.0 million during Q1 2023, and registered a low of -$27.0 million during Q3 2025.
  • Over the past 5 years, Rxo's median Other Working Capital Changes value was -$1.0 million (recorded in 2022), while the average stood at -$2.2 million.
  • Per our database at Business Quant, Rxo's Other Working Capital Changes soared by 150000.0% in 2023 and then crashed by 42500.0% in 2024.
  • Rxo's Other Working Capital Changes (Quarter) stood at -$10.0 million in 2021, then soared by 80.0% to -$2.0 million in 2022, then skyrocketed by 150.0% to $1.0 million in 2023, then skyrocketed by 1300.0% to $14.0 million in 2024, then crashed by 92.86% to $1.0 million in 2025.
  • Its last three reported values are $1.0 million in Q4 2025, -$27.0 million for Q3 2025, and -$3.0 million during Q2 2025.